AAAAAA
Results:
1-18
|
Results: 18
Authors:
Sofuoglu, M
Brown, S
Babb, DA
Hatsukami, DK
Citation: M. Sofuoglu et al., Depressive symptoms modulate the subjective and physiological response to cocaine in humans, DRUG AL DEP, 63(2), 2001, pp. 131-137
Authors:
Kotlyar, M
Golding, M
Hatsukami, DK
Jamerson, BD
Citation: M. Kotlyar et al., Effect of nonnicotine pharmacotherapy on smoking behavior, PHARMACOTHE, 21(12), 2001, pp. 1530-1548
Authors:
Sofuoglu, M
Babb, DA
Hatsukami, DK
Citation: M. Sofuoglu et al., Progesterone treatment during the early follicular phase of the menstrual cycle: Effects on smoking behavior in women, PHARM BIO B, 69(1-2), 2001, pp. 299-304
Authors:
Sofuoglu, M
Nelson, D
Babb, DA
Hatsukami, DK
Citation: M. Sofuoglu et al., Intravenous cocaine increases plasma epinephrine and norepinephrine in humans, PHARM BIO B, 68(3), 2001, pp. 455-459
Authors:
Sofuoglu, M
Brown, S
Babb, DA
Pentel, PR
Hatsukami, DK
Citation: M. Sofuoglu et al., Carvedilol affects the physiological and behavioral response to smoked cocaine in humans, DRUG AL DEP, 60(1), 2000, pp. 69-76
Authors:
Sofuoglu, M
Nelson, D
Dudish-Poulsen, S
Lexau, B
Pentel, PR
Hatsukami, DK
Citation: M. Sofuoglu et al., Predictors of cardiovascular response to smoked cocaine in humans, DRUG AL DEP, 57(3), 2000, pp. 239-245
Authors:
Sofuoglu, M
Dudish-Poulsen, S
Nicodemus, KK
Babb, DA
Hatsukami, DK
Citation: M. Sofuoglu et al., Characteristics of research volunteers for inpatient cocaine studies: Focus on selection bias, ADDICT BEHA, 25(5), 2000, pp. 785-790
Authors:
Sofuoglu, M
Brown, S
Dudish-Poulsen, S
Hatsukami, DK
Citation: M. Sofuoglu et al., Individual differences in the subjective response to smoked cocaine in humans, AM J DRUG A, 26(4), 2000, pp. 591-602
Authors:
Sofuoglu, M
Brown, S
Babb, DA
Pentel, PR
Hatsukami, DK
Citation: M. Sofuoglu et al., Effects of labetalol treatment on the physiological and subjective response to smoked cocaine, PHARM BIO B, 65(2), 2000, pp. 255-259
Authors:
Hatsukami, DK
Grillo, M
Boyle, R
Allen, S
Jensen, J
Bliss, R
Brown, S
Citation: Dk. Hatsukami et al., Treatment of spit tobacco users with transdermal nicotine system and mint snuff, J CONS CLIN, 68(2), 2000, pp. 241-249
Authors:
Lando, HA
Hatsukami, DK
Citation: Ha. Lando et Dk. Hatsukami, Low rates of physicians counseling adolescents about smoking: a critical wake-up call, J NAT CANC, 91(21), 1999, pp. 1795-1796
Authors:
Hatsukami, DK
Mooney, ME
Citation: Dk. Hatsukami et Me. Mooney, Pharmacological and behavioral strategies for smoking cessation, J CL P MED, 6(1), 1999, pp. 11-38
Authors:
Hecht, SS
Hatsukami, DK
Bonilla, LE
Hochalter, JB
Citation: Ss. Hecht et al., Quantitation of 4-oxo-4-(3-pyridyl)butanoic acid and enantiomers of 4-hydroxy-4-(3-pyridlyl)butanoic acid in human urine: A substantial pathway of nicotine metabolism, CHEM RES T, 12(2), 1999, pp. 172-179
Authors:
Sofuoglu, M
Pentel, PR
Bliss, RL
Goldman, AI
Hatsukami, DK
Citation: M. Sofuoglu et al., Effects of phenytoin on cocaine self-administration in humans, DRUG AL DEP, 53(3), 1999, pp. 273-275
Authors:
Hatsukami, DK
Jensen, J
Boyle, R
Grillo, M
Bliss, R
Citation: Dk. Hatsukami et al., Characteristics of smokeless tobacco users seeking treatment, ADDICT BEHA, 24(4), 1999, pp. 551-557
Authors:
Daughton, DM
Fortmann, SP
Glover, ED
Hatsukami, DK
Heatley, SA
Lichtenstein, E
Repsher, L
Millatmal, T
Killen, JD
Nowak, RT
Ullrich, F
Patil, KD
Rennard, SI
Citation: Dm. Daughton et al., The smoking cessation efficacy of varying doses of nicotine patch deliverysystems 4 to 5 years post-quit day, PREV MED, 28(2), 1999, pp. 113-118
Authors:
Hecht, SS
Carmella, SG
Chen, ML
Koch, JFD
Miller, AT
Murphy, SE
Jensen, JA
Zimmerman, CL
Hatsukami, DK
Citation: Ss. Hecht et al., Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation, CANCER RES, 59(3), 1999, pp. 590-596
Authors:
Hughes, J
Hatsukami, DK
Citation: J. Hughes et Dk. Hatsukami, Errors in using tobacco withdrawal scale, TOB CONTROL, 7(1), 1998, pp. 92-93
Risultati:
1-18
|